4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 0.35 AUD 14.75% Market Closed
Market Cap: 157.7m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

4DX Price Targets Summary
4DMedical Ltd

Wall Street analysts forecast 4DX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4DX is 0.8 AUD with a low forecast of 0.66 AUD and a high forecast of 1.05 AUD.

4DX Lowest Forecast
Wall Street Target
0.66 AUD
88% Upside
4DX Average Forecast
Wall Street Target
0.8 AUD
128% Upside
4DX Highest Forecast
Wall Street Target
1.05 AUD
200% Upside
Lowest
Price Target
0.66 AUD
88% Upside
Average
Price Target
0.8 AUD
128% Upside
Highest
Price Target
1.05 AUD
200% Upside
4DMedical Ltd Competitors:
Price Targets
M7T
Mach7 Technologies Ltd
173% Upside
OPRX
OPTIMIZERx Corp
16% Downside
INSP
Inspire Medical Systems Inc
55% Upside
BMT
Beamtree Holdings Ltd
108% Upside
M7T
Mach7 Technologies Ltd
173% Upside
OPRX
OPTIMIZERx Corp
16% Downside
INSP
Inspire Medical Systems Inc
55% Upside
BMT
Beamtree Holdings Ltd
108% Upside
S
SOPH
Sophia Genetics SA
139% Upside
2413
M3 Inc
1% Downside
2192
Medlive Technology Co Ltd
11% Upside
C
CCLD
CareCloud Inc
106% Upside

Revenue
Forecast

Revenue Estimate
4DMedical Ltd

For the last 6 years the compound annual growth rate for 4DMedical Ltd's revenue is 30%. The projected CAGR for the next 3 years is 145%.

30%
Past Growth
145%
Estimated Growth
Estimates Accuracy
-57%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
4DMedical Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
15%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
4DMedical Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
What are analyst estimates?

See Also

Summary
4DX intrinsic value, competitors valuation, and company profile.
DCF Valuation
4DX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
4DX stock valuation using valuation multiples.
Wall Street Estimates
4DX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
4DX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 4DX's stock price target?
Price Target
0.8 AUD

According to Wall Street analysts, the average 1-year price target for 4DX is 0.8 AUD with a low forecast of 0.66 AUD and a high forecast of 1.05 AUD.

What is 4DMedical Ltd's Revenue forecast?
Projected CAGR
145%

For the last 6 years the compound annual growth rate for 4DMedical Ltd's revenue is 30%. The projected CAGR for the next 3 years is 145%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.